Beth Grous - 26 Feb 2026 Form 4 Insider Report for Generate Biomedicines, Inc. (GENB)

Role: Chief People Officer
Signature: /s/ Michael Wolf, Attorney-in-Fact
Issuer symbol: GENB
Transactions as of: 26 Feb 2026
Net transactions value: +$4,800
Form type: 4
Filing time: 02 Mar 2026, 18:05:17 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Grous Beth	Chief People Officer	GENERATE BIOMEDICINES, INC., 101 SOUTH STREET, SUITE 900, SOMERVILLE	/s/ Michael Wolf, Attorney-in-Fact	02 Mar 2026	0002109144

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GENB	Common Stock	Purchase	$4,800	+300		$16.00	300	02 Mar 2026	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GENB	Stock Option (Right to Buy)	Award	$0	+114,020		$0.000000	114,020	26 Feb 2026	Common Stock	114,020	$16.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.